Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1999-10-01 (26 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAMPIGNELLES (89350), Yonne
PHARMACIE DE LA LIBERTE : revenue, balance sheet and financial ratios
PHARMACIE DE LA LIBERTE is a French company
founded 26 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAMPIGNELLES (89350),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA LIBERTE (SIREN 428691257)
Indicator
2025
2024
2023
2021
2020
2019
2018
Revenue
N/C
N/C
1 784 971 €
1 628 380 €
1 651 829 €
1 486 229 €
1 331 219 €
Net income
83 598 €
86 596 €
140 860 €
101 821 €
121 705 €
83 910 €
91 955 €
EBITDA
N/C
N/C
166 692 €
122 343 €
139 417 €
107 984 €
90 692 €
Net margin
N/C
N/C
7.9%
6.3%
7.4%
5.6%
6.9%
Revenue and income statement
In 2025, PHARMACIE DE LA LIBERTE generates positive net income of 84 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 92 k€ -> 84 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
83 598 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 192%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
191.947%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
28.909%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA LIBERTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2023
2024
2025
Debt ratio
237.041
206.289
200.408
210.842
145.289
193.172
191.947
Financial autonomy
26.453
28.37
28.309
27.156
32.754
29.611
28.909
Repayment capacity
9.638
6.902
5.704
6.46
3.888
None
None
Cash flow / Revenue
6.576%
7.008%
8.224%
7.344%
8.497%
None%
None%
Sector positioning
Debt ratio
191.952025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA LIBERTE (191.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
28.91%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-5 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA LIBERTE (28.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.89 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DE LA LIBERTE (3.89) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 102.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
102.621
Liquidity indicators evolution PHARMACIE DE LA LIBERTE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
177.98
102.956
155.162
150.885
92.244
115.486
102.621
Interest coverage
14.355
9.201
6.911
7.401
13.296
None
None
Sector positioning
Liquidity ratio
102.622025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch
In 2025, the liquidity ratio of PHARMACIE DE LA LIBERTE (102.62) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
13.3x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DE LA LIBERTE (13.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA LIBERTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2023
2024
2025
Operating WCR
155 992 €
54 872 €
103 190 €
28 448 €
43 857 €
0 €
0 €
Inventory turnover (days)
12
11
12
13
11
0
0
Customer payment term (days)
4
6
5
5
6
0
0
Supplier payment term (days)
41
39
44
38
46
0
0
Positioning of PHARMACIE DE LA LIBERTE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA LIBERTE is estimated at
1 327 964 €
(range 901 162€ - 2 083 758€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
901k€1327k€2083k€
1 327 964 €Range: 901 162€ - 2 083 758€
NAF 5 année 2025
Valuation method used
Net Income Multiple
83 598 €
×
15.9x
=1 327 964 €
Range: 901 163€ - 2 083 759€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA LIBERTE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA LIBERTE
What is the revenue of PHARMACIE DE LA LIBERTE ?
The revenue of PHARMACIE DE LA LIBERTE in 2023 is 1.8 M€.
Is PHARMACIE DE LA LIBERTE profitable?
Yes, PHARMACIE DE LA LIBERTE generated a net profit of 84 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA LIBERTE ?
The headquarters of PHARMACIE DE LA LIBERTE is located in CHAMPIGNELLES (89350), in the department Yonne.
Where to find the tax return of PHARMACIE DE LA LIBERTE ?
The tax return of PHARMACIE DE LA LIBERTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA LIBERTE operate?
PHARMACIE DE LA LIBERTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart